(Q42590464)

3 November 2017

The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. (English)

1 reference

3 November 2017

1 reference

7

Glimelius B

1 reference

3 November 2017

1

Nygren P

1 reference

3 November 2017

Csoka K

2

1 reference

3 November 2017

Jonsson B

3

1 reference

3 November 2017

Fridborg H

4

1 reference

3 November 2017

Bergh J

5

1 reference

3 November 2017

Hagberg H

6

1 reference

3 November 2017

Brodin O

8

1 reference

3 November 2017

Tholander B

9

1 reference

3 November 2017

Kreuger A

10

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

British Journal of Cancer

3 November 2017

1 reference

3 November 2017

71

1 reference

3 November 2017

3

1 reference

3 November 2017

478-481

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.97

3 November 2017

0 references

cites work

Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

A novel dye exclusion method for testing in vitro chemosensitivity of human tumors

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Phase II Trial of Taxol in Patients with Metastatic Renal Cell Carcinoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Taxol: the first of the taxanes, an important new class of antitumor agents.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Altered plasma membrane ultrastructure in multidrug-resistant cells.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Paclitaxel-induced cytotoxicity--the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033622

Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype

16 August 2018

1 reference

12 December 2020

Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients

1 reference

12 December 2020

Greater sensitivity of human multidrug-resistant (mdr) cancer cells to polyunsaturated fatty acids than their non-mdr counterparts

1 reference

12 December 2020

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.97

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

7880727

1 reference